Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.

McCann FE, Palfreeman AC, Andrews M, Perocheau DP, Inglis JJ, Schafer P, Feldmann M, Williams RO, Brennan FM.

Arthritis Res Ther. 2010;12(3):R107. doi: 10.1186/ar3041.

2.

New advances in musculoskeletal pain.

Bove SE, Flatters SJ, Inglis JJ, Mantyh PW.

Brain Res Rev. 2009 Apr;60(1):187-201. doi: 10.1016/j.brainresrev.2008.12.012. Review.

3.

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells.

Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO.

J Exp Med. 2008 Oct 27;205(11):2491-7. doi: 10.1084/jem.20072707.

4.

Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen.

Inglis JJ, Criado G, Medghalchi M, Andrews M, Sandison A, Feldmann M, Williams RO.

Arthritis Res Ther. 2007;9(5):R113.

5.

Analysing the effect of novel therapies on cytokine expression in experimental arthritis.

Williams RO, Inglis JJ, Simelyte E, Criado G, Sumariwalla PF.

Int J Exp Pathol. 2005 Oct;86(5):267-78. Review.

6.

The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation.

Inglis JJ, Nissim A, Lees DM, Hunt SP, Chernajovsky Y, Kidd BL.

Arthritis Res Ther. 2005;7(4):R807-16.

Items per page

Supplemental Content

Loading ...
Support Center